Skip to main content
. 2020 Aug 8;6:112. doi: 10.1186/s40814-020-00657-3

Table 1.

Participant characteristics at baseline

Characteristic Pediatric tubes (n = 100) Adult tubes (n = 100)
Age, year, mean (SD) 55 (16.7) 57 (18.5)
Women, n (%) 45 (45) 51 (51)
Race, n (%)
 White 38 (38) 39 (39)
 Black 36 (36) 46 (46)
 Other 26 (26) 15 (15)
ICU admission hemoglobin, g/dL
 Median (IQR) 11.4 (9.3–12.7) 11.3 (9.2–12.7)
 Mean (SD) 11.4 (2.4) 11.1 (2.3)
ICU admission hemoglobin category, n (%)
 7–9.49 g/dL 27 (27) 29 (29)
 9.5–11.99 g/dL 32 (32) 32 (32)
 ≥ 12 g/dL 41 (41) 39 (39)
Time from ICU admission to randomization, h, median (IQR) 5.3 (1.5–8) 5.7 (2.6–8.6)
Estimated blood volume per participant, L, median (IQR)a 4.9 (4.2–5.6) 4.6 (3.9–5.4)
Chronic hemodialysis, n (%) 12 (12) 12 (12)
Chronic kidney disease but no dialysis, n (%) 13 (13) 11 (11)
Active malignancy, n (%) 5 (5) 5 (5)
Recent history of anemia, n (%)b 45 (45) 47 (47)
Charlson comorbidity index, median (IQR)c 3.0 (2–6) 4.0 (2–5)
ICU admission diagnosis, n (%)d
 Infection 55 (55) 46 (46)
 Acute cardiovascular disorder 21 (21) 24 (24)
 Acute renal failure 40 (40) 31 (31)
 Metabolic disorder 32 (32) 36 (36)
 Non-infectious inflammatory disordere 19 (19) 11 (11)
 Other 22 (22) 31 (31)
Invasive mechanical ventilation, n (%) 50 (50) 51 (51)
APACHE II score, median (IQR)f 22.0 (14-29) 23.0 (16-28)

SD standard deviation, ICU intensive care unit, IQR interquartile range, APACHE Acute Physiology and Chronic Health Evaluation

aThe blood volumes were estimated according to Nadler method, which is based on the participant’s gender, height, and weight

bA recent history of anemia was defined as hemoglobin below 13 g/dL in men or 11.6 g/dL in women in the preceding 6 months

cThe Charlson comorbidity index measures the effect of coexisting conditions on mortality, with scores ranging from 0 to 33. Higher scores indicate greater burden of illness

dThe diagnosis are not mutually exclusive

eNon-infectious inflammatory disorders included conditions such as acute pancreatitis, asthma exacerbation, and chronic obstructive pulmonary disease exacerbation

fAPACHE II scores are assessed on a scale from 0 to 71. Higher scores indicate higher risk of death